RIC8A | RIC8 guanine nucleotide exchange factor A | | | | | | Expressed in all |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins
| | | | | Group enriched |
IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
RNH1 | Ribonuclease/angiogenin inhibitor 1 | Plasma proteins
| | | | | Expressed in all |
LRRC56 | Leucine rich repeat containing 56 | | | | | | Tissue enhanced |
IRF7 | Interferon regulatory factor 7 | Transcription factors
| | | | | Expressed in all |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SCT | Secretin | Predicted secreted proteins
| | | | | Tissue enhanced |
DEAF1 | DEAF1 transcription factor | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
CEND1 | Cell cycle exit and neuronal differentiation 1 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC25A22 | Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PIDD | P53-induced death domain protein | Enzymes
| | | | | Expressed in all |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
AP2A2 | Adaptor-related protein complex 2, alpha 2 subunit | Plasma proteins
| | | | | Expressed in all |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC5AC | Mucin 5AC, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Tissue enriched |
MUC5B | Mucin 5B, oligomeric mucus/gel-forming | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TOLLIP | Toll interacting protein | Plasma proteins
| | | | | Expressed in all |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
TNNI2 | Troponin I type 2 (skeletal, fast) | Disease related genes
| | | | | Tissue enriched |
LSP1 | Lymphocyte-specific protein 1 | | | | | | Expressed in all |
TNNT3 | Troponin T type 3 (skeletal, fast) | Disease related genes
| | | | | Tissue enriched |
INS-IGF2 | INS-IGF2 readthrough | Predicted secreted proteins
| | | | | Tissue enriched |
INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
STIM1 | Stromal interaction molecule 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TRIM68 | Tripartite motif containing 68 | | | | | | Expressed in all |
HBB | Hemoglobin, beta | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
HBD | Hemoglobin, delta | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
UBQLN3 | Ubiquilin 3 | | | | | | Tissue enriched |
TRIM5 | Tripartite motif containing 5 | | | | | | Expressed in all |
C11orf42 | Chromosome 11 open reading frame 42 | | | | | | Tissue enriched |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
ARFIP2 | ADP-ribosylation factor interacting protein 2 | Predicted secreted proteins
| | | | | Expressed in all |
RRP8 | Ribosomal RNA processing 8, methyltransferase, homolog (yeast) | | | | | | Expressed in all |
TAF10 | TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa | | | | | | Expressed in all |
TPP1 | Tripeptidyl peptidase I | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
DCHS1 | Dachsous cadherin-related 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
RBMXL2 | RNA binding motif protein, X-linked-like 2 | | | | | | Tissue enriched |
SYT9 | Synaptotagmin IX | Predicted membrane proteins
| | | | | Tissue enhanced |
PPFIBP2 | PTPRF interacting protein, binding protein 2 (liprin beta 2) | Plasma proteins
| | | | | Expressed in all |
RIC3 | RIC3 acetylcholine receptor chaperone | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
RPL27A | Ribosomal protein L27a | Ribosomal proteins
| | | | | Expressed in all |